Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing TherapyROMERO, Ignacio; BAST, Robert C.Endocrinology (Philadelphia). 2012, Vol 153, Num 4, pp 1593-1602, issn 0013-7227, 10 p.Article

Molecular therapeutics and pharmocogenomicsBAST, Robert C; MILLS, Gordon B.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S84-S87, issn 0090-8258, 2Conference Paper

Proceedings of the eighth biennial international forum on ovarian cancerBAST, Robert C; MILS, Gordon; GERSHENSON, David et al.Gynecologic oncology (Print). 2003, Vol 88, Num 1, issn 0090-8258, 161 p., 2Conference Proceedings

The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosisROSEN, Daniel G; MERCADO-URIBE, Imelda; GONG YANG et al.Cancer. 2006, Vol 107, Num 11, pp 2730-2740, issn 0008-543X, 11 p.Article

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancerMENON, Usha; SKATES, Steven J; ORAM, David et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7919-7926, issn 0732-183X, 8 p.Article

Use of CA-125 in clinical trial evaluation of new therapeutic drugs for ovarian cancerRUSTIN, Gordon J. S; BAST, Robert C; KELLOFF, Gary J et al.Clinical cancer research. 2004, Vol 10, Num 11, pp 3919-3926, issn 1078-0432, 8 p.Article

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancersLUO, Robert Z; XIANJUN FANG; MARQUEZ, Rebecca et al.Oncogene (Basingstoke). 2003, Vol 22, Num 19, pp 2897-2909, issn 0950-9232, 13 p.Article

Hereditary cancer: Lessons from Li-Fraumeni syndromeSTRONG, Louise C.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S4-S7, issn 0090-8258, 2Conference Paper

Hereditary ovarian cancer: What we knowBOYD, Jeff.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S8-S10, issn 0090-8258, 2Conference Paper

Expression profiling and the study of ovarian cancerLIU, Edison T.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S14-S15, issn 0090-8258, 2Conference Paper

Cancer screening: Translation of principles into practiceKRAMER, Barnett S.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S71-S74, issn 0090-8258, 2Conference Paper

Current issues in the design of ovarian cancer treatment trialsTRIMBLE, Edward; BERRY, Donald; GORE, Martin et al.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S122-S123, issn 0090-8258, 2Conference Paper

The granulin-epithelin precursor: A putative new growth factor for ovarian cancerJONES, Monica Brown; SPOONER, Michele; KOHN, Elise C et al.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S136-S139, issn 0090-8258, 2Conference Paper

Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer modelYOUNG, Travis; FANG MEI; JINSONG LIU et al.Oncogene (Basingstoke). 2005, Vol 24, Num 40, pp 6174-6184, issn 0950-9232, 11 p.Article

Expression of epidermal growth factor receptor family in transgenic mouse models of human breast cancerMULLER, William J.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S43-S46, issn 0090-8258, 2Conference Paper

Ovarian cancer risk assessment and the potential for early detectionURBAN, Nicole.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S75-S79, issn 0090-8258, 2Conference Paper

Ovarian cancer screeningJACOBS, Ian.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S80-S83, issn 0090-8258, 2Conference Paper

Clinical trial designBERRY, Donald A.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S114-S116, issn 0090-8258, 2Conference Paper

In the shadow of illness-supporting women with ovarian cancerMAUGHAN, Karen.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S129-S133, issn 0090-8258, 2Conference Paper

The impact of cancer chemopreventionWAUN KI HONG.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S56-S58, issn 0090-8258, 2Conference Paper

The spiritual aspects of survivorshipSILLS, Deborah.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S134-S135, issn 0090-8258, 2Conference Paper

Dasatinib Induces Autophagic Cell Death in Human Ovarian CancerLE, Xiao-Feng; WEIQUN MAO; ZHEN LU et al.Cancer. 2010, Vol 116, Num 21, pp 4980-4990, issn 0008-543X, 11 p.Article

Experimental models of epithelial ovarian carcinogenesisAUERSPERG, Nelly.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S47-S51, issn 0090-8258, 2Conference Paper

Clinical trial design problems in ovarian cancerSTEVENSON, Anna; GORE, Martin.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S117-S121, issn 0090-8258, 2Conference Paper

Patient supportBRUERA, Eduardo; SWEENEY, Catherine.Gynecologic oncology (Print). 2003, Vol 88, Num 1, pp S124-S128, issn 0090-8258, 2Conference Paper